miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 8, Pages 1023-1037
Publisher
Springer Nature
Online
2016-08-15
DOI
10.1038/onc.2016.270
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of miR-100 in regulating apoptosis of breast cancer cells
- (2015) Yi Gong et al. Scientific Reports
- p53 regulation: Teamwork between RING domains of Mdm2 and MdmX
- (2012) Xinjiang Wang CELL CYCLE
- PIR2/Rnf144B regulates epithelial homeostasis by mediating degradation of p21WAF1 and p63
- (2012) F Conforti et al. ONCOGENE
- Signature miRNAs Involved in the Innate Immunity of Invertebrates
- (2012) Geng Yang et al. PLoS One
- Apoptosis Inhibitor ARC Promotes Breast Tumorigenesis, Metastasis, and Chemoresistance
- (2011) C. M. Medina-Ramirez et al. CANCER RESEARCH
- Ubiquitin–proteasome pathway and cellular responses to oxidative stress
- (2011) Fu Shang et al. FREE RADICAL BIOLOGY AND MEDICINE
- E3 Ligase STUB1/CHIP Regulates NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Accumulation in Aged Brain, a Process Impaired in Certain Alzheimer Disease Patients
- (2011) Peter Tsvetkov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Non-coding RNAs in human disease
- (2011) Manel Esteller NATURE REVIEWS GENETICS
- IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation
- (2010) Giovanni Benard et al. EMBO JOURNAL
- Ancient animal microRNAs and the evolution of tissue identity
- (2010) Foteini Christodoulou et al. NATURE
- Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer
- (2010) S. Cairo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The vital link between the ubiquitin–proteasome pathway and DNA repair: Impact on cancer therapy
- (2009) Akira Motegi et al. CANCER LETTERS
- Ubiquitination, Ubiquitin-like Modifiers, and Deubiquitination in Viral Infection
- (2009) Marisa K. Isaacson et al. Cell Host & Microbe
- MicroRNA-125b is a novel negative regulator of p53
- (2009) M. T.N. Le et al. GENES & DEVELOPMENT
- Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy
- (2009) Brian J. Henson et al. GENES CHROMOSOMES & CANCER
- Targeting the ubiquitin–proteasome system to activate wild-type p53 for cancer therapy
- (2009) Nerea Allende-Vega et al. SEMINARS IN CANCER BIOLOGY
- Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis
- (2009) Katia R.M. Leite et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development
- (2008) Francesca Bernassola et al. CANCER CELL
- MicroRNA Expression Profiles in Serous Ovarian Carcinoma
- (2008) E. J. Nam et al. CLINICAL CANCER RESEARCH
- Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue
- (2008) T.-S. Wong et al. CLINICAL CANCER RESEARCH
- RYBP stabilizes p53 by modulating MDM2
- (2008) Deng Chen et al. EMBO REPORTS
- Mdm2 and Mdm4 Loss Regulates Distinct p53 Activities
- (2008) J. A. Barboza et al. MOLECULAR CANCER RESEARCH
- Diversity of degradation signals in the ubiquitin–proteasome system
- (2008) Tommer Ravid et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The p53 family and programmed cell death
- (2008) E C Pietsch et al. ONCOGENE
- Apoptosis: controlled demolition at the cellular level
- (2007) Rebecca C. Taylor et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation